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Introduction: Children undergoing hematopoietic stem cell
transplantation (HSCT) are at risk of developing vitamin D
deﬁciency (VDD). However, data on vitamin D status and its
correlation with bone mineral density (BMD) in the long
term survivors after childhood HSCT is limited. The aim of
this study was to determine the prevalence of VDD among
long term survivors after HSCT in childhood, and to evaluate
the correlations between vitamin D and BMD.
Methods: A retrospective study was carried out in patients
seen in Long Term follow-up Clinic (LTFC) at our institution
from January 2011 to July 2012. VDD and insufﬁciency (VDI)
were deﬁned as serum 25-hydroxyvitamin D (25-OHD) <15
ng/mL and 15-30 ng/mL, respectively. BMD was measured
using dual-energy radiograph absorptiometry (Hologic Del-
phi). Lumbar, total body, and hip BMD Z scores were deter-
mined using manufacturer's normative data based on age.
Spearman's correlation was performed to assess correlation
between serum 25-OHD levels and different BMD variables.
Results: Ninety eight patients underwent 103 HSCTs
between 1990 and 2010. Fifty two (53%) patients were > 5
years out of transplant. A total of 114 vitamin D levels were
recorded for the 98 patients, the median 25-OHD level was
26 (range 7 - 68 ng/mL). In 68/114 (60%) observations the 25-
OHD levels were less than < 30ng/mL. Of these, 10 (9%)
patients had VDD (levels < 15ng/mL, while 58 (51%) had VDI.
There were no signiﬁcant correlations between 25-OHD
levels and age at HSCT, gender, underlying diagnosis, type of
transplant, or development of acute or chronic GVHD (Table
2). Therewas a trend towards lower 25-OHD levels after non-
TBI based conditioning regimen (P ¼ .047). BMD was per-
formed in 83 patients (85%). Low BMD was found in nearly
one-third to half of patients tested: 29%, 54%, and 33% of the
patients had BMDlumbar, BMDhip and BMDWB Z scores of<
-1.0, respectively, while 5%, 9% and 5% of the patients had
BMDlumbar, BMDhip and BMDWB Z scores < -2.5, respec-
tively. The median Z scores of the BMDlumbar, BMDhip, and
the BMDWB were -0.3 (range - 4.2 to 2.4), -1.1 (range -3.3 to
1.9), and -0.4 (range -5.4 to 2.7) respectively. In patients with
BMD < -2.5 and < -1.0, the corresponding median 25-OHD
was 26 (range 7 - 62 ng/mL) and there was no signiﬁcant
association. Spearman correlation between 25-OHD D level,
BMDWB and BMDlumbar showed a correlation coefﬁcient of
-0.24 (P value: 0.0409) and -0.22 (P value: 0.0546) respec-
tively. There was no correlation between normal vitamin D
levels, VDI and VDD with BMD of the hip, lumbar spine and
whole body.
Discussion: Low 25-OHD (<30 ng/mL) was common (60%) in
long term survivors after HSCT during childhood. Similar to
other reports, VDD and VDI was seen in 9%, and 51% of the
patients respectively. There was only a weak correlation of
the 25-OHD levels with BMD of whole body and the lumbar
spine, suggesting that factors other than hypovitaminosis D
might have contributed to low BMD. There was a small trend
of lower 25-OHD levels after non-TBI based conditioning.199
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Background: Consultation for abdominal pain (AP) in pedi-
atric patients following allogeneic hematopoietic stem cell
transplant (HSCT) is common. Non HSCT related GI inﬂam-
mation (infectious and non-infectious) has been associated
with post-inﬂammatory abdominal pain and functional
gastrointestinal disorders (FGID) in ashighas60%of cases. The
presence of AP and FGIDs after HSCT has not been described.
We hypothesized that AP is frequent after HSCT given the
inﬂammation from conditioning, GVHD and infection.
Methods: Patients >2 years from HSCT were offered
a Questionnaire of Pediatric Gastrointestinal Symptoms.
Thosewith active gut GVHDwere excluded. After completing
the surveys, chart reviews were performed focusing on
demographics, transplant characteristics, adverse events and
long-term outcomes.
Results: 48 patients completed the survey;7 (15%) had
abdominal complaints. 3 patients were diagnosed with AP
related FGID (dyspepsia, IBS, functional abdominal pain); 4
had AP that did not ﬁt criteria for diagnosis. The group with
AP were transplanted for high risk malignancy (71%) e
ALL(2), AML (1), Anaplastic Lymphoma (1) and Stage IV
Neuroblastoma(1). There was an increased incidence of total
body irradiation (TBI) containing regimens (57% vs 39%) in
patients with AP, but conditioning regimen intensity ie.
myeloablative versus reduced intensity (MA/RIC) was not
associated with AP. There was an increased incidence of
aGVHD (43.9% vs 29.3%), however surprisingly incidence of
GI aGVHD was equal between groups. Those with AP had
a higher incidence of second transplants (28.5% vs 4.9%),
which were performed for relapse. The AP group also had
more frequent abdominal infections (40% vs. 15%). The time
interval from HSCT in the AP/FGID group is shorter (4 years),
compared to the non-AP group (6 years), P ¼ .029; however
there were no other signiﬁcant demographic differences
between the two groups.
Conclusions: AP and FGIDs are common after HSCT in chil-
dren.APwasmore frequent inpatients<5yrs fromHSCT.Data
suggested that TBI, abdominal infections and relapse may be
associated with later development of abdominal pain. Larger
studies are needed for further evaluation and to conﬁrm these
ﬁnding. The investigation of post-HSCT AP and FGIDs may
help understand the role of inﬂammation, stress, coping and
families on the development of functional abdominal pain.
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